Pharmacy benefit managers are working on a proposal to change certain business practices in an effort to curb potential regulation from the Trump administration, Bloomberg reported Sept. 24.  Here are four things to know: 

Bristol-Myers Squibb is the latest drugmaker to raise drug prices abroad to align with President Donald Trump’s “most favored nation” drug pricing policy, but has not lowered U.S. prices in return, the Financial Times reported Sept. 22. The drugmaker will…

A federal judge refused to block Maine from enforcing a new state law protecting 340B pricing for contract pharmacy arrangements, according to a news release from the American Hospital Association. The preliminary injunctions were filed by AbbVie and Novartis. U.S.…

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

The FDA has granted accelerated approval for the elamipretide injection, the first treatment for Barth syndrome in patients weighing at least 30 kg.  Barth syndrome is a life threatening disease of the mitochondria. The injection works by binding the inner…

Walmart has expanded same-day pharmacy services to include refrigerated and reconstituted medications.  The expansion includes refrigerated access for medications such as insulin, GLP-1s and pediatric amoxicillin, according to a Sept. 22 news release from the company. Refrigerated medications make up…

CVS Health subsidiary Omnicare has filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Northern District of Texas.  The filing comes after a recent ruling in a civil case in the U.S. District Court for the Southern…

The Trump administration is exploring the creation of a government website to connect patients directly with pharmaceutical companies offering discounted prescription drugs, according to people familiar with the matter, Bloomberg reported Sept. 19.  The proposed platform, possibly dubbed “TrumpRx,” would…

The FDA has approved a new injectable version of cancer drug Keytruda as Merck seeks to protect its market dominance.  Here are five things to know: 

A study found GLP-1 drugs such as Zepbound and Wegovy may offer benefits for people living with psoriasis, HealthDay reported Sept. 18.  In the study, presented Sept. 18 at the European Academy of Dermatology and Venereology, researchers found that GLP-1s…